Clinical Trial

A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 26, 2024 (before its estimated August 10, 2024 completion). Its status may not reflect the trial's current state.
Summary
Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06463938
Lead Sponsor Dow University of Health Sciences
Conditions Dentin Sensitivity, Hypersensitivity, Cervical Lesion
Enrollment 120 participants
Start Date 2024-05-12
Primary Completion 2024-08-10 (estimated)
Study Completion 2024-10-10 (estimated)
Updated on ClinicalTrials.gov 2024-07-26